• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液来源细胞:法布里病患者有前途的诊断工具。

Urine-derived cells: a promising diagnostic tool in Fabry disease patients.

机构信息

Department II of Internal Medicine Medicine and Center for Rare Diseases Cologne, University Hospital of Cologne, Cologne, Germany.

Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

出版信息

Sci Rep. 2018 Jul 23;8(1):11042. doi: 10.1038/s41598-018-29240-w.

DOI:10.1038/s41598-018-29240-w
PMID:30038331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6056427/
Abstract

Fabry disease is a lysosomal storage disorder resulting from impaired alpha-galactosidase A (α-Gal A) enzyme activity due to mutations in the GLA gene. Currently, powerful diagnostic tools and in vivo research models to study Fabry disease are missing, which is a major obstacle for further improvements in diagnosis and therapy. Here, we explore the utility of urine-derived primary cells of Fabry disease patients. Viable cells were isolated and cultured from fresh urine void. The obtained cell culture, modeling the renal epithelium, is characterized by patient-specific information. We demonstrate that this non-invasive source of patient cells provides an adequate cellular in vivo model as cells exhibit decreased α-Gal A enzyme activity and concomitant globotriaosylceramide accumulation. Subsequent quantitative proteomic analyses revealed dysregulation of endosomal and lysosomal proteins indicating an involvement of the Coordinated Lysosomal Expression and Regulation (CLEAR) network in the disease pathology. This proteomic pattern resembled data from our previously described human podocyte model of Fabry disease. Taken together, the employment of urine-derived primary cells of Fabry disease patients might have diagnostic and prognostic implications in the future. Our findings pave the way towards a more detailed understanding of pathophysiological mechanisms and may allow the development of future tailored therapeutic strategies.

摘要

法布里病是一种溶酶体贮积病,由于 GLA 基因突变导致α-半乳糖苷酶 A(α-Gal A)酶活性受损而引起。目前,缺乏强大的诊断工具和用于研究法布里病的体内研究模型,这是进一步改善诊断和治疗的主要障碍。在这里,我们探讨了利用法布里病患者的尿液来源原代细胞的可能性。我们从新鲜的尿液中分离并培养了有活力的细胞。获得的细胞培养物模拟了肾上皮,具有患者特异性信息。我们证明,这种非侵入性的患者细胞来源为细胞提供了充足的体内模型,因为细胞表现出 α-Gal A 酶活性降低和伴随的Globotriaosylceramide 积累。随后的定量蛋白质组学分析显示内体和溶酶体蛋白的失调,表明协调溶酶体表达和调节(CLEAR)网络参与疾病病理学。这种蛋白质组模式与我们之前描述的法布里病人类足细胞模型的数据相似。总之,法布里病患者尿液来源的原代细胞的应用可能具有未来的诊断和预后意义。我们的发现为深入了解病理生理机制铺平了道路,并可能允许未来开发出有针对性的治疗策略。

相似文献

1
Urine-derived cells: a promising diagnostic tool in Fabry disease patients.尿液来源细胞:法布里病患者有前途的诊断工具。
Sci Rep. 2018 Jul 23;8(1):11042. doi: 10.1038/s41598-018-29240-w.
2
Enzyme Replacement Therapy Clears Gb3 Deposits from a Podocyte Cell Culture Model of Fabry Disease but Fails to Restore Altered Cellular Signaling.酶替代疗法可清除法布里病足细胞培养模型中的Gb3沉积物,但无法恢复改变的细胞信号传导。
Cell Physiol Biochem. 2019;52(5):1139-1150. doi: 10.33594/000000077.
3
Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique.在安德森-法布里病中进行靶向尿液显微镜检查:一种廉价、敏感且特异的诊断技术。
Nephrol Dial Transplant. 2011 Oct;26(10):3195-202. doi: 10.1093/ndt/gfr084. Epub 2011 Mar 7.
4
Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer.腺病毒介导的基因转移纠正法布里小鼠的酶和溶酶体储存缺陷。
Hum Gene Ther. 1999 Jul 1;10(10):1667-82. doi: 10.1089/10430349950017671.
5
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.输注α-半乳糖苷酶A可减少法布里病患者组织中球三糖神经酰胺的蓄积。
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):365-70. doi: 10.1073/pnas.97.1.365.
6
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies.法布雷病中一种药物伴侣对 α-半乳糖苷酶 A 活性和神经节苷脂 GD3 清除的安全性和药效学影响:两项 2 期临床研究报告。
Orphanet J Rare Dis. 2012 Nov 24;7:91. doi: 10.1186/1750-1172-7-91.
7
Biomarkers for Diagnosing and Staging of Fabry Disease.用于诊断和分期法布里病的生物标志物。
Curr Med Chem. 2018;25(13):1530-1537. doi: 10.2174/0929867324666170616102112.
8
Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.采用 LC-MS/MS 法对法布雷病患者尿液中的乳糖基神经酰胺、半乳糖基神经酰胺和Globotriaosylceramide 进行分离和分析。
Anal Chem. 2017 Dec 19;89(24):13382-13390. doi: 10.1021/acs.analchem.7b03609. Epub 2017 Nov 27.
9
Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study.尿总半乳糖基神经酰胺及其同工型鉴定法布里病女性患者:一项诊断性试验研究。
Am J Kidney Dis. 2011 May;57(5):673-81. doi: 10.1053/j.ajkd.2010.10.046. Epub 2010 Dec 24.
10
No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.在一个携带有α-半乳糖苷酶 A 基因 E66Q 突变的患者心脏中未发现神经节苷脂 GM3 的蓄积。
Mol Genet Metab. 2012 Dec;107(4):711-5. doi: 10.1016/j.ymgme.2012.10.018. Epub 2012 Oct 24.

引用本文的文献

1
Urine-derived renal epithelial cells for deep phenotyping and transcriptomic response to therapy in Fabry disease.用于法布里病深度表型分析及治疗转录组反应的尿液来源肾上皮细胞
Clin Sci (Lond). 2025 Jul 28;139(14):791-808. doi: 10.1042/CS20255570.
2
Bibliometric analysis of MXRA7 gene research trajectory: trends and insights (2015-2024).MXRA7基因研究轨迹的文献计量分析:趋势与见解(2015 - 2024年)
Discov Oncol. 2025 Jun 3;16(1):989. doi: 10.1007/s12672-025-02824-5.
3
Urinary Myeloid Bodies as a Biomarker for Early Diagnosis and Monitoring of Enzyme Replacement Therapy in Fabry Disease.

本文引用的文献

1
Neuropathic pain in a Fabry disease rat model.法布里病大鼠模型中的神经性疼痛。
JCI Insight. 2018 Mar 22;3(6):99171. doi: 10.1172/jci.insight.99171.
2
A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease.一种用于定量血浆神经酰胺三己糖苷的简单方法:在法布雷病中的应用。
Mol Genet Metab. 2017 Sep;122(1-2):121-125. doi: 10.1016/j.ymgme.2017.08.004. Epub 2017 Aug 19.
3
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.
尿髓样小体作为法布里病早期诊断及酶替代治疗监测的生物标志物
Kidney Dis (Basel). 2025 Apr 14;11(1):332-341. doi: 10.1159/000545604. eCollection 2025 Jan-Dec.
4
ATM knock out alters calcium signalling and augments contraction in skeletal muscle cells differentiated from human urine-derived stem cells.ATM基因敲除会改变钙信号传导,并增强从人尿液衍生干细胞分化而来的骨骼肌细胞的收缩能力。
Cell Death Discov. 2025 Apr 15;11(1):177. doi: 10.1038/s41420-025-02485-x.
5
Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs.法布里病女性患者:关于诊断、临床管理、当前挑战及未满足需求的专家意见
Front Cardiovasc Med. 2025 Mar 12;12:1536114. doi: 10.3389/fcvm.2025.1536114. eCollection 2025.
6
GLA deficiency causes cardiac hypertrophy via enhanced autophagy.γ-亚麻酸缺乏通过增强自噬导致心脏肥大。
Sci China Life Sci. 2025 Jun;68(6):1689-1702. doi: 10.1007/s11427-023-2731-0. Epub 2025 Feb 17.
7
Dynll1-PI31 Interaction Enhances Proteolysis Through the Proteasome, Representing a Novel Therapeutic Target for INF2-Related FSGS.Dynll1与PI31的相互作用通过蛋白酶体增强蛋白水解作用,是与INF2相关的局灶节段性肾小球硬化症的新型治疗靶点。
Kidney360. 2025 Jan 1;6(1):38-48. doi: 10.34067/KID.0000000659. Epub 2024 Dec 2.
8
A Novel Synonymous Variant in SQSTM1 Causes Neurodegeneration With Ataxia, Dystonia, and Gaze Palsy Revealed by Urine-Derived Cells-Based Functional Analysis.一种新型 SQSTM1 同义突变导致的以共济失调、肌张力障碍和眼球运动障碍为特征的神经退行性疾病:基于尿液衍生细胞的功能分析揭示。
Mol Genet Genomic Med. 2024 Nov;12(11):e70044. doi: 10.1002/mgg3.70044.
9
The role of tubular cells in the pathogenesis of Fabry nephropathy.肾小管细胞在法布里肾病发病机制中的作用。
Front Cardiovasc Med. 2024 Apr 5;11:1386042. doi: 10.3389/fcvm.2024.1386042. eCollection 2024.
10
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.α-突触核蛋白的积累介导法布里肾病中的足细胞损伤。
J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782.
法布里病酶替代疗法长期疗效的回顾性研究:预后因素分析
PLoS One. 2017 Aug 1;12(8):e0182379. doi: 10.1371/journal.pone.0182379. eCollection 2017.
4
Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease.经典型和迟发型法布里病患者干血斑与血清中溶血型Gb3水平的相关性
Mol Genet Metab. 2017 Aug;121(4):320-324. doi: 10.1016/j.ymgme.2017.06.006. Epub 2017 Jun 17.
5
Quantitative deep mapping of the cultured podocyte proteome uncovers shifts in proteostatic mechanisms during differentiation.培养的足细胞蛋白质组的定量深度图谱揭示了分化过程中蛋白质稳态机制的变化。
Am J Physiol Cell Physiol. 2016 Sep 1;311(3):C404-17. doi: 10.1152/ajpcell.00121.2016. Epub 2016 Jun 29.
6
Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.由CK1α诱导的Jade-1S磷酸化有助于细胞周期进程。
Cell Cycle. 2016;15(8):1034-45. doi: 10.1080/15384101.2016.1152429.
7
The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes.泛素连接酶Ubr4控制足突蛋白/MEC-2超复合物的稳定性。
Hum Mol Genet. 2016 Apr 1;25(7):1328-44. doi: 10.1093/hmg/ddw016. Epub 2016 Jan 19.
8
Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGS.一种新型ACTN4突变的三层蛋白质组学特征揭示了其在局灶节段性肾小球硬化中的致病潜力。
Hum Mol Genet. 2016 Mar 15;25(6):1152-64. doi: 10.1093/hmg/ddv638. Epub 2016 Jan 5.
9
Fabry disease.法布里病
Handb Clin Neurol. 2015;132:231-48. doi: 10.1016/B978-0-444-62702-5.00017-2.
10
DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome.DNA复制应激是CEP290相关Joubert综合征肾脏表型的基础。
J Clin Invest. 2015 Sep;125(9):3657-66. doi: 10.1172/JCI80657. Epub 2015 Aug 24.